ClinicalTrials.Veeva

Menu

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

G

Genesys

Status

Completed

Conditions

Renal Failure
Respiratory Failure
Surgical Site Infection
Sepsis

Treatments

Drug: Novolin R (human recombinant Insulin)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00282594
GRMC 050023

Details and patient eligibility

About

We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.

Full description

While evidence exists for using tight glycemic control in the critically ill cardiac surgical patient, other patient populations have yet to be studied. We performed a prospective randomized trial for using intensive insulin therapy in the general and vascular critically ill surgical patient population. We will compare tight glycemic control versus conventional glycemic control to determine if there is a benefit to the normalization of blood glucose levels in this patient population

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Patients undergoing a general or vascular surgical procedure requiring admission to the surgical intensive care unit as a result of ventilatory requirement, vasopressor support, or physiologic instability

Exclusion Criteria:

  • Under age 18

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems